Nektar Therapeutics (NKTR) Stock Chart & Stock Price History $0.75 -0.03 (-3.60%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.76 +0.01 (+1.06%) As of 05/2/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Nektar Therapeutics Stock Price Performance 5 Day Performance+1.53%1 Month Performance+36.26%3 Month Performance-3.44%6 Month Performance-43.46%Year-To-Date Performance-19.14%1 Year Performance-52.10% Receive NKTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address NKTR Stock Chart for Sunday, May, 4, 2025 NKTR Chart by TradingView Nektar Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$0.78$0.75-3.60%$0.80$0.741.40 million shs$139.95 million05/01/2025$0.80$0.78-1.94%$0.82$0.741.74 million shs$145.18 million04/30/2025$0.74$0.80+7.40%$0.82$0.722.42 million shs$148.05 million04/29/2025$0.76$0.74-2.54%$0.77$0.72950,548 shs$137.85 million04/28/2025$0.78$0.76-1.95%$0.80$0.711.82 million shs$141.44 million04/25/2025$0.74$0.78+4.98%$0.81$0.743.16 million shs$144.25 million04/24/2025$0.69$0.74+7.66%$0.75$0.692.05 million shs$137.40 million04/23/2025$0.66$0.69+3.28%$0.71$0.671.25 million shs$127.63 million04/22/2025$0.63$0.66+6.09%$0.67$0.631.08 million shs$123.57 million04/21/2025$0.64$0.63-1.65%$0.65$0.611.29 million shs$116.48 million Get the Latest News and Ratings for NKTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$0.64$0.64$0.66$0.601.99 million shs$118.44 million04/17/2025$0.61$0.64+4.88%$0.66$0.601.99 million shs$118.44 million04/16/2025$0.64$0.61-4.85%$0.67$0.592.26 million shs$112.93 million04/15/2025$0.60$0.64+5.60%$0.68$0.592.43 million shs$118.68 million04/14/2025$0.62$0.60-2.23%$0.65$0.582.80 million shs$112.39 million04/11/2025$0.50$0.62+23.76%$0.65$0.538.02 million shs$114.96 million04/10/2025$0.51$0.50-2.25%$0.54$0.471.03 million shs$92.89 million04/09/2025$0.49$0.51+3.72%$0.53$0.433.61 million shs$95.03 million04/09/2025$0.49$0.51+3.72%$0.53$0.433.61 million shs$95.03 million04/08/2025$0.49$0.49+0.39%$0.58$0.473.13 million shs$91.62 million04/08/2025$0.49$0.49+0.39%$0.58$0.473.13 million shs$91.62 million04/07/2025$0.55$0.49-11.14%$0.55$0.474.39 million shs$91.27 million04/04/2025$0.60$0.55-8.09%$0.60$0.534.73 million shs$102.71 million04/03/2025$0.66$0.60-8.88%$0.66$0.583.74 million shs$111.76 million Related Companies OMER Stock Chart ASMB Stock Chart CPIX Stock Chart LLY Stock Chart JNJ Stock Chart ABBV Stock Chart MRK Stock Chart PFE Stock Chart BMY Stock Chart ZTS Stock Chart Receive NKTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nektar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NKTR) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NKTR Stock Free NKTR Stock Alerts